S
Sandrine Pirard
Researcher at National Institute on Drug Abuse
Publications - 9
Citations - 685
Sandrine Pirard is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Benzoylecgonine & Poison control. The author has an hindex of 7, co-authored 7 publications receiving 570 citations. Previous affiliations of Sandrine Pirard include University of Maryland, College Park.
Papers
More filters
Journal ArticleDOI
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Marisol S. Castaneto,David A. Gorelick,Nathalie A. Desrosiers,Nathalie A. Desrosiers,Rebecca L. Hartman,Rebecca L. Hartman,Sandrine Pirard,Marilyn A. Huestis +7 more
TL;DR: A comprehensive review, based on a systematic electronic literature search, of SC epidemiology and pharmacology and their clinical implications is presented, showing in vitro and animal in vivo studies show SC pharmacological effects 2-100 times more potent than THC.
Journal ArticleDOI
Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses.
Sofia Bouhlal,Kayla N. Ellefsen,Mikela B. Sheskier,Erick Singley,Sandrine Pirard,David A. Gorelick,Marilyn A. Huestis,Lorenzo Leggio,Lorenzo Leggio +8 more
TL;DR: Findings show a significant effect of acute IV cocaine administration on some appetitive hormones and suggest potential associations between these hormones and cocaine-related cardiorespiratory and subjective responses and additional research is needed to further investigate the potential mechanisms underlined.
Journal ArticleDOI
Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration.
Kayla N. Ellefsen,Kayla N. Ellefsen,Jose Luiz Costa,Jose Luiz Costa,Marta Concheiro,Sebastien Anizan,Allan J. Barnes,Sandrine Pirard,David A. Gorelick,Marilyn A. Huestis +9 more
TL;DR: DBS offer advantages for monitoring cocaine intake; however, differences between capillary and venous blood and DBS concentration variability must be addressed.
Journal ArticleDOI
Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.
Kayla N. Ellefsen,Kayla N. Ellefsen,Marta Concheiro,Sandrine Pirard,David A. Gorelick,Marilyn A. Huestis +5 more
TL;DR: It is demonstrated that different confirmatory OF cutoffs can be selected to produce shorter or longer cocaine and metabolite detection windows to address specific needs of clinical and forensic drug testing programs.
Journal ArticleDOI
Quantification of cocaine and metabolites in exhaled breath by liquid chromatography-high-resolution mass spectrometry following controlled administration of intravenous cocaine.
Kayla N. Ellefsen,Kayla N. Ellefsen,Marta Concheiro,Olof Beck,David A. Gorelick,Sandrine Pirard,Marilyn A. Huestis +6 more
TL;DR: Results suggest that the sensitive and specific method developed and validated for cocaine, BE, EME, and norcocaine quantification in breath reflects the drug in oral fluid as well as lung microparticles, while the filter reflects only drug-ladenmicroparticles.